280 related articles for article (PubMed ID: 15791506)
21. Cefpodoxime for antimicrobial prophylaxis in neutropenia: a retrospective case series.
Wojenski DJ; Barreto JN; Wolf RC; Tosh PK
Clin Ther; 2014 Jun; 36(6):976-81. PubMed ID: 24832560
[TBL] [Abstract][Full Text] [Related]
22. [Fluoroquinolone prophylaxis utility during chemotherapy-induced severe neutropenia in patients with acute leukemia, with fluoroquinolone resistance high prevalence, in a reference hospital in Mexico City].
Ugarte-Torres A; Villasis-Keever A; Hernández-Bribiesca ME; Crespo-Solis E; Ruiz-Palacios GM; Sifuentes-Osornio J; Ponce-De-León-Garduño A
Rev Invest Clin; 2006; 58(6):547-54. PubMed ID: 17432285
[TBL] [Abstract][Full Text] [Related]
23. Editorial comment. Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy.
Hernandez-Graulau JM
Urology; 2009 Aug; 74(2):338-9; author reply 339. PubMed ID: 19646618
[No Abstract] [Full Text] [Related]
24. Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia.
Cometta A; Calandra T; Bille J; Glauser MP
N Engl J Med; 1994 Apr; 330(17):1240-1. PubMed ID: 8139646
[No Abstract] [Full Text] [Related]
25. [Empirical antimicrobial therapy in a patient with neutropenia].
Anttila VJ; Ruotsalainen E
Duodecim; 2002; 118(21):2241-7. PubMed ID: 12486961
[No Abstract] [Full Text] [Related]
26. Infections caused by viridans streptococci in patients with neutropenia.
Tunkel AR; Sepkowitz KA
Clin Infect Dis; 2002 Jun; 34(11):1524-9. PubMed ID: 12015700
[TBL] [Abstract][Full Text] [Related]
27. Recent changes in bacterial epidemiology and the emergence of fluoroquinolone-resistant Escherichia coli among patients with haematological malignancies: results of a prospective study on 823 patients at a single institution.
Cattaneo C; Quaresmini G; Casari S; Capucci MA; Micheletti M; Borlenghi E; Signorini L; Re A; Carosi G; Rossi G
J Antimicrob Chemother; 2008 Mar; 61(3):721-8. PubMed ID: 18218645
[TBL] [Abstract][Full Text] [Related]
28. [Prophylaxis of infection in neutropenic patients. Guidelines of the Working Party on Infections in Hematology and Oncology].
Kern WV; Beyer J; Böhme A; Buchheidt D; Cornely O; Einsele H; Kisro J; Krüger W; Maschmeyer G; Ruhnke M; Schmidt CA; Schwartz S; Szelenyi H;
Dtsch Med Wochenschr; 2000 Dec; 125(51-52):1582-8. PubMed ID: 11199452
[No Abstract] [Full Text] [Related]
29. [7/10 Antibiotic drug therapy and infectious risk].
Soins; 2007 Sep; (718):59-60. PubMed ID: 17970578
[No Abstract] [Full Text] [Related]
30. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
Klastersky J
J Antimicrob Chemother; 2009 May; 63 Suppl 1():i14-5. PubMed ID: 19372173
[TBL] [Abstract][Full Text] [Related]
31. Clinical and microbiological impact of discontinuation of fluoroquinolone prophylaxis in patients with prolonged profound neutropenia.
Verlinden A; Jansens H; Goossens H; van de Velde AL; Schroyens WA; Berneman ZN; Gadisseur AP
Eur J Haematol; 2014 Oct; 93(4):302-8. PubMed ID: 24750350
[TBL] [Abstract][Full Text] [Related]
32. Antibiotic prophylaxis in neutropenic patients.
Gafter-Gvili A; Paul M; Fraser A; Leibovici L
Isr Med Assoc J; 2007 Jun; 9(6):460-2. PubMed ID: 17642395
[No Abstract] [Full Text] [Related]
33. Sepsis due to fluoroquinolone-resistant Escherichia coli after transrectal ultrasound-guided prostate needle biopsy.
Young JL; Liss MA; Szabo RJ
Urology; 2009 Aug; 74(2):332-8. PubMed ID: 19464041
[TBL] [Abstract][Full Text] [Related]
34. Fluoroquinolone prophylaxis: a word of caution.
Lingaratnam S; Thursky KA; Slavin MA
Leuk Lymphoma; 2011 Jan; 52(1):5-6. PubMed ID: 21067448
[No Abstract] [Full Text] [Related]
35. Antibiotic prophylaxis in neutropenic children with acute leukemia: Do the presently available data really support this practice?
Calitri C; Ruberto E; Castagnola E
Eur J Haematol; 2018 Dec; 101(6):721-727. PubMed ID: 30107054
[TBL] [Abstract][Full Text] [Related]
36. [Against preventive antibiotic therapy in neutropenia].
Baro J; Richard C
Sangre (Barc); 1994 Jun; 39(3):165-6. PubMed ID: 7940044
[No Abstract] [Full Text] [Related]
37. Safe fluoroquinolones prophylaxis in blood cancer patients with chemotherapy-induced neutropenia and Glucose-6-Phosphate-Dehydrogenase deficiency.
Sanna M; Caocci G; Orrù F; Ledda A; Vacca A; Piras E; Fozza C; Deias P; Tidore G; Dore F; La Nasa G
J Clin Pharm Ther; 2017 Dec; 42(6):733-737. PubMed ID: 28597476
[TBL] [Abstract][Full Text] [Related]
38. Fluoroquinolone prophylaxis during neutropenia: what can we expect nowadays?
Mikulska M; Cordonnier C
Clin Microbiol Infect; 2018 Jul; 24(7):678-679. PubMed ID: 29549060
[No Abstract] [Full Text] [Related]
39. Fluoroquinolone prophylaxis against febrile neutropenia in areas with high fluoroquinolone resistance--an Asian perspective.
Ng ES; Liew Y; Koh LP; Hsu LY
J Formos Med Assoc; 2010 Sep; 109(9):624-31. PubMed ID: 20863989
[TBL] [Abstract][Full Text] [Related]
40. Antibiotic prophylaxis for prevention of spontaneous bacterial peritonitis in patients without gastrointestinal bleeding.
Segarra-Newnham M; Henneman A
Ann Pharmacother; 2010 Dec; 44(12):1946-54. PubMed ID: 21098755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
